EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Genetic and Nongenetic Determinants of Variable Warfarin Dose Requirements: A Report from North India

Navjot Kaur, Avaneesh Pandey, Nusrat Shafiq, Ankur Gupta, Reena Das, Harkant Singh, Jasmina Ahluwalia, Samir Malhotra

Public Health Genomics · 2022 · 25 (1-2) · 52-60

DOI: 10.1159/000519462 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Public Health Genomics, online erschienen am 21.10.2021. Verfasst von Navjot Kaur und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, VMMC & Safdarjung Hospital, New Delhi, India. Hauptthemen laut MEDLINE: Warfarin, Cytochrome P-450 CYP2C9, Anticoagulants. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Warfarin is widely used and will continue to be prescribed especially in developing countries due to its low cost. Given the huge patient load requiring anticoagulation, there is a need to develop strategies to optimize warfarin therapy for ensuring safe and effective anticoagulation. In the present work, we aimed at elucidating the association of genetic and nongenetic variables with warfarin dose requirement in patients attending the cardiovascular clinic in a tertiary care center of North India.

Methods

This was a prospective study conducted over 1 year. Patient demographic and clinical details were captured in customized case record forms. Genotyping was done using the polymerase chain reaction-restriction fragment length polymorphism method. Pharmacogenetic influence of CYP2C9 (rs1799853 and rs1057910) and VKORC1 (rs9923231) variant alleles was studied. The association of genetic and nongenetic factors with warfarin dose was quantified using a stepwise multivariate linear regression model.

Results

Two hundred and forty patients were screened. Data from 82 eligible patients were used for quantifying the association of genetic and nongenetic factors with warfarin dose. A descriptive model based on CYP2C9*3 (rs1057910) and VKORC1 (rs9923231) variant alleles and BMI was developed. The model explains nearly half of the interindividual variation in warfarin dose requirement.

Conclusion

The model explains nearly half of the interindividual variation in warfarin dose in patients with atrial fibrillation and or requiring valve replacement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

WarfarinCytochrome P-450 CYP2C9AnticoagulantsHumansIndiaVitamin K Epoxide ReductasesMaleFemaleMiddle AgedProspective StudiesPolymorphism, Single NucleotideGenotypeAllelesAgedDose-Response Relationship, Drug

Stichwörter der Autor:innen

CoumarinDose optimizationGenetic polymorphismsPrecision medicineWarfarin

Substanzen

WarfarinCytochrome P-450 CYP2C9Vitamin K Epoxide ReductasesVKORC1 protein, humanAnticoagulantsCYP2C9 protein, human

Autor:innen und Institutionen

  • Department of Pharmacology, VMMC & Safdarjung Hospital, New Delhi, India.
  • Clinical Pharmacology Resident, Department of Pharmacology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Department of Pharmacology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Department of Pharmacology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India, nusrat.shafiq.pgi@gmail.com.
  • Department of Cardiology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Department of Hematology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Zitieren

APA

Kaur, N., Pandey, A., Shafiq, N., Gupta, A., Das, R., Singh, H., Ahluwalia, J., & Malhotra, S. (2022). Genetic and Nongenetic Determinants of Variable Warfarin Dose Requirements: A Report from North India. Public Health Genomics, 25(1-2), 52-60. https://doi.org/10.1159/000519462

Vancouver

Kaur N, Pandey A, Shafiq N, Gupta A, Das R, Singh H, et al. Genetic and Nongenetic Determinants of Variable Warfarin Dose Requirements: A Report from North India. Public Health Genomics. 2022;25(1-2):52-60. doi:10.1159/000519462

BibTeX
@article{Kaur2022,
  author = {Kaur, Navjot and Pandey, Avaneesh and Shafiq, Nusrat and Gupta, Ankur and Das, Reena and Singh, Harkant and Ahluwalia, Jasmina and Malhotra, Samir},
  title = {Genetic and Nongenetic Determinants of Variable Warfarin Dose Requirements: A Report from North India},
  journal = {Public Health Genomics},
  year = {2022},
  volume = {25},
  number = {1-2},
  pages = {52--60},
  doi = {10.1159/000519462}
}
Kostenlos starten →